13F Holdings
中文EN

INMD InMode Ltd. Annual reports only

Electromedical & Electrotherapeutic Apparatus · Nasdaq · SEC CIK 1742692 · Fiscal year ends 12/31

Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY-6.2%
TTM net income YoY-48.2%
TTM EPS YoY-36.4%
Revenue 3-yr CAGR-6.6%
Net income 3-yr CAGR-16.6%

Margins

Gross margin78.5%
Operating margin23.0%
Net margin25.3%
FCF margin22.7%
EBITDA margin23.2%

Returns

ROE13.5%
ROA12.1%
ROIC (approx.)15.6%
Asset turnover0.48x

Leverage & solvency

Liabilities / assets10.9%
Debt / equity0.00x
Current ratio9.88x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.91x
Accruals ratio1.1%
Payout ratio—
Capex / revenue0.3%

Factor history charts and full statement history on Pro 🔒

Financial statements

Annual Quarterly (none) Export CSV 🔒
Line item FY2025*2025-12-31FY2024*2024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$370.50M$394.82M$492.05M$454.27M$357.56M
Cost of revenue$79.53M$77.75M$80.71M$73.48M$53.59M
Gross profit$290.97M$317.07M$411.34M$380.79M$303.97M
R&D expense$13.32M$13.14M$13.41M$12.43M$9.53M
SG&A expense$11.69M$10.03M$9.23M$9.93M$8.41M
Operating income$85.39M$112.53M$195.66M$197.85M$167.48M
Pretax income$110.33M$143.47M$217.27M$201.47M$168.00M
Income tax$16.50M-$37.81M$19.35M$39.95M$2.93M
Net income$93.83M$181.28M$197.92M$161.52M$164.97M
EBITDA$86.08M$113.26M$196.28M$198.53M$167.99M
EPS (basic)1.452.292.371.962.03
EPS (diluted)1.432.252.301.891.92
Weighted avg. shares (diluted)65.44M80.60M85.95M85.40M86.02M
Banking
Net interest income——$4.71M$1.21M-$1.22M
Balance sheet
Cash & equivalents$302.54M$155.33M$144.41M$97.54M$68.14M
Short-term investments$83.63M$267.69M$373.65M$374.59M$294.53M
Receivables$43.50M$36.34M$42.36M$27.00M$20.24M
Inventory$74.05M$59.55M$45.09M$39.90M$21.03M
Current assets$698.62M$714.45M$845.33M$629.37M$470.11M
PP&E, net$2.60M$2.32M$2.38M$2.30M$1.40M
Total assets$766.43M$785.67M$863.29M$644.41M$478.54M
Current liabilities$70.74M$69.85M$64.14M$82.02M$51.85M
Total liabilities$83.23M$81.85M$75.91M$89.79M$62.74M
Shareholders' equity$683.20M$703.81M$787.37M$554.62M$415.80M
Shares outstanding63.36M69.56M83.98M82.54M82.98M
Cash flow statement
Operating cash flow$85.26M$132.66M$176.83M$181.58M$174.88M
Capital expenditure$972,000$669,000$705,000$1.57M$939,000
Free cash flow$84.28M$132.00M$176.12M$180.00M$173.95M
Investing cash flow$186.03M$162.21M-$136.06M-$109.47M-$160.11M
Financing cash flow-$126.06M-$282.77M$5.50M-$41.09M-$15.02M
Depreciation & amortization$695,000$728,000$623,000$680,000$517,000
Stock-based compensation$11.13M$16.57M$23.60M$24.45M$11.96M
Share buybacks$127.44M$285.38M$0$42.64M$35.37M

Free plan shows the latest 5 periods; Pro shows all 9 🔒

· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.